Drug class in one race

SIRPα (Signal regulatory protein alpha) drugs for Non-Small Cell Lung Cancer

3 tracked SIRPα (Signal regulatory protein alpha) drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the SIRPα (Signal regulatory protein alpha) page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.

1 Phase 1/22 Phase 1

The roster

← all SIRPα (Signal regulatory protein alpha) drugs